ISIS Financial Facts

Gain (loss) on investments, net: 1.06M
Total operating expenses: 41.74M
See Full Income Statement

Contracts receivable: 1.17M
Long-term financing liability for leased facility: 70.73M
See Full Balance Sheet

Earnings History for Isis Pharmaceuticals, Inc. (ISIS)

  |   Expand Research on ISIS
Next EPS Date 8/5/13 *Est. EPS Growth Rate +91.7% *Last Qtr.
Average EPS % Beat Rate +33.7% Revenue Growth Rate +86.9% *Last Qtr.
Average % Move 1-Wk after EPS +4.7%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/7/13 Q113 -$0.02-$0.02 $0.00$43.36M$45.24M N/A / N/A N/A +6.1% Details
2/28/13 Q412 -$0.03-$0.23 +$0.20$19.9M$15.78M N/A / N/A N/A +62.2% Details
8/6/12 Q212 -$0.01-$0.10 +$0.09$47.3M$40.06M N/A / N/A N/A +91.1% Details
2/28/11 Q410 -$0.14-$0.22 +$0.08$26.4M$22.55M N/A / N/A N/A +155% Details
11/6/12 Q312 -$0.37-$0.26 -$0.11$11.6M$23.11M N/A / N/A N/A +164.7% Details
5/5/11 Q111 -$0.20-$0.19 -$0.01$21.1M$25.69M N/A / N/A N/A +165.3% Details
2/29/12 Q411 -$0.20-$0.18 -$0.02$32.4M$30.3M N/A / N/A N/A +168.1% Details
11/7/11 Q311 -$0.27-$0.20 -$0.07$20.7M$25.33M N/A / N/A N/A +178.7% Details
Like ISIS Earnings? Also take a look at SNY, AZN, RGLS, ALNY

ISIS Earnings News